Condition: Acute Porphyrias · Cutaneous Porphyrias · Sponsor: The American Porphyrias Expert Collaborative
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
This description comes directly from the study's public registry record.
Kristen P Wheeden, DrPH · 301-461-9889 · kristen@porphyria.org
Always discuss trial participation with your own doctor first.
| University of Alabama, Birmingham | Birmingham, Alabama, United States | Recruiting |
| University of California, Los Angeles | Los Angeles, California, United States | Not Yet Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| University of Illinois at Chicago | Chicago, Illinois, United States | Not Yet Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| Carolinas Medical Center and HealthCare System | Charlotte, North Carolina, United States | Terminated |
| Wake Forest University Health Sciences | Winston-Salem, North Carolina, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| Thomas Jefferson University | Philadelphia, Pennsylvania, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01561157